Andreas Harsch

Andreas Harsch has a diverse work experience in the pharmaceutical industry. Andreas is currently serving as the VP Preclinical Development at Kymera Therapeutics since November 2022. Prior to that, they worked at Frontier Medicines as the Executive Director and Head of DMPK & Toxicology Lead from November 2021 to November 2022.

Before joining Frontier Medicines, Andreas held a significant role at Novartis, where they worked as the Director of Global Metabolism and Pharmacokinetics Oncology & Immuno Oncology Disease Area Representative, NIBR. Andreas'sresponsibilities included PKSciences/Clin. Pharm support of NIBR hematology portfolio for CBT/NIDU/Dax, and representation on Hematology SWG, discovery, preclinical, and clinical projects. Andreas worked with Novartis from June 2014 to October 2021.

Prior to Novartis, they served as an Associate Director at AstraZeneca from October 2011 to May 2014, where they contributed their expertise in pharmacokinetics.

During their tenure at Merck, Andreas held two roles. From December 2007 to September 2011, they served as an Associate Director/Sr. Investigator DMPK, and from August 2004 to November 2007, they held the position of Senior Research Fellow.

Andreas started their career as a Senior Scientist II at Abbott Bioresearch Center from March 2001 to August 2004. Andreas also worked as a Senior Scientist I at BASF Bioresearch Center from December 1999 to February 2001.

Overall, Andreas Harsch has gained extensive experience in preclinical development, DMPK, toxicology, metabolism, and pharmacokinetics throughout their career in various roles at renowned pharmaceutical companies like Kymera Therapeutics, Frontier Medicines, Novartis, AstraZeneca, Merck, Abbott Bioresearch Center, and BASF Bioresearch Center.

Andreas Harsch completed a Post-Doc & Staff Scientist degree in Analytical Chemistry from Northeastern University between 1996 and 1999. Prior to that, they earned a Ph.D. in Organic Chemistry from the University of Cincinnati, spanning from 1991 to 1996. Andreas'seducation began at the University of Stuttgart, where they obtained a Vordiplom degree in Chemistry from 1987 to 1991.